Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Grunenthal

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Grunenthal's 2013 immunology sales performance.

Big Pharma, Little Pharma

Big Pharma, Little Pharma

to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and Ferring with women’s health.

Gilead and ViiV among winners at PM Society Digital Awards

Gilead and ViiV among winners at PM Society Digital Awards Allergan, Glenmark, Grunenthal, Merck Serono, MSD and Novartis and all won Gold as well. .

Europe's public-private alliance targets pain management

Europe's public-private alliance targets pain management an effort led by Winfried Meissner of the University of Jena and Hiltrud Liedgens of drugmaker Grünenthal.

Pharma's first 'performance marketing' agency launched

Pharma's first 'performance marketing' agency launched Prior to that he spent a decade in pharma, first at Sanofi and then Grünenthal, rising to senior marketing manager at the latter before moving agency-side.

Pursuing better outcomes for people with pain

Pursuing better outcomes for people with pain Grünenthal is an entrepreneurial, science-based pharmaceutical company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. ... Joensson has more than 30 years’ experience of working in patient

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics